U.S. Trial With AstraZeneca's Coronavirus Vaccine Expected to Resume Soon

Clinical trials with an experimental coronavirus vaccine from AstraZeneca (NYSE:AZN) that was put on pause over a month ago could start up again soon in the United States. Trials with the candidate, AZD1222, were paused on Sept. 6, after a clinical trial volunteer in the U.K. experienced an adverse event.